Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo

Potchanapond Graidist, Michio Yazawa, Moltira Tonganunt, Akiko Nakatomi, Curtis Chun Jen Lin, Jui Yoa Chang, Amornrat Phongdara, Kenichi Fujise

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Fortilin, a 172-amino-acid polypeptide present both in the cytosol and nucleus, possesses potent anti-apoptotic activity. Although fortilin is known to bind Ca2+, the biochemistry and biological significance of such an interaction remains unknown. In the present study we report that fortilin must bind Ca2+ in order to protect cells against Ca2+-dependent apoptosis. Using a standard Ca2+-overlay assay, we first validated that full-length fortilin binds Ca2+ and showed that the N-terminus (amino acids 1-72) is required for its Ca2+-binding. We then used flow dialysis and CD spectropolarimetry assays to demonstrate that fortilin binds Ca2+ with a dissociation constant (Kd) of approx. 10 μM and that the binding of fortilin to Ca2+ induces a significant change in the secondary structure of fortilin. In order to evaluate the impact of the binding of fortilin to Ca2+ in vivo, we measured intracellular Ca2+ levels upon thapsigargin challenge and found that the lack of fortilin in the cell results in the exaggerated elevation of intracellular Ca2+ in the cell. We then tested various point mutants of fortilin for their Ca2+ binding and identified fortilin(E58A/E60A) to be a double-point mutant of fortilin lacking the ability of Ca2+-binding. We then found that wildtype fortilin, but not fortilin(E58A/E60A), protected cells against thapsigargin-induced apoptosis, suggesting that the binding of fortilin to Ca2+ is required for fortilin to protect cells against Ca2+-dependent apoptosis. Together, these results suggest that fortilin is an intracellular Ca2+ scavenger, protecting cells against Ca2+-dependent apoptosis by binding and sequestering Ca2+ from the downstream Ca2+-dependent apoptotic pathways.

Original languageEnglish (US)
Pages (from-to)181-191
Number of pages11
JournalBiochemical Journal
Volume408
Issue number2
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Apoptosis
Thapsigargin
Assays
Amino Acids
Biochemistry
Dialysis
Cytosol
Peptides

Keywords

  • Apoptosis
  • Ca
  • Cell death
  • Fortilin
  • Thapsigargin

ASJC Scopus subject areas

  • Biochemistry
  • Medicine(all)

Cite this

Graidist, P., Yazawa, M., Tonganunt, M., Nakatomi, A., Lin, C. C. J., Chang, J. Y., ... Fujise, K. (2007). Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo. Biochemical Journal, 408(2), 181-191. https://doi.org/10.1042/BJ20070679

Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo. / Graidist, Potchanapond; Yazawa, Michio; Tonganunt, Moltira; Nakatomi, Akiko; Lin, Curtis Chun Jen; Chang, Jui Yoa; Phongdara, Amornrat; Fujise, Kenichi.

In: Biochemical Journal, Vol. 408, No. 2, 01.12.2007, p. 181-191.

Research output: Contribution to journalArticle

Graidist, P, Yazawa, M, Tonganunt, M, Nakatomi, A, Lin, CCJ, Chang, JY, Phongdara, A & Fujise, K 2007, 'Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo', Biochemical Journal, vol. 408, no. 2, pp. 181-191. https://doi.org/10.1042/BJ20070679
Graidist P, Yazawa M, Tonganunt M, Nakatomi A, Lin CCJ, Chang JY et al. Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo. Biochemical Journal. 2007 Dec 1;408(2):181-191. https://doi.org/10.1042/BJ20070679
Graidist, Potchanapond ; Yazawa, Michio ; Tonganunt, Moltira ; Nakatomi, Akiko ; Lin, Curtis Chun Jen ; Chang, Jui Yoa ; Phongdara, Amornrat ; Fujise, Kenichi. / Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo. In: Biochemical Journal. 2007 ; Vol. 408, No. 2. pp. 181-191.
@article{1efac1eda78944fdad234ab3582a6759,
title = "Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo",
abstract = "Fortilin, a 172-amino-acid polypeptide present both in the cytosol and nucleus, possesses potent anti-apoptotic activity. Although fortilin is known to bind Ca2+, the biochemistry and biological significance of such an interaction remains unknown. In the present study we report that fortilin must bind Ca2+ in order to protect cells against Ca2+-dependent apoptosis. Using a standard Ca2+-overlay assay, we first validated that full-length fortilin binds Ca2+ and showed that the N-terminus (amino acids 1-72) is required for its Ca2+-binding. We then used flow dialysis and CD spectropolarimetry assays to demonstrate that fortilin binds Ca2+ with a dissociation constant (Kd) of approx. 10 μM and that the binding of fortilin to Ca2+ induces a significant change in the secondary structure of fortilin. In order to evaluate the impact of the binding of fortilin to Ca2+ in vivo, we measured intracellular Ca2+ levels upon thapsigargin challenge and found that the lack of fortilin in the cell results in the exaggerated elevation of intracellular Ca2+ in the cell. We then tested various point mutants of fortilin for their Ca2+ binding and identified fortilin(E58A/E60A) to be a double-point mutant of fortilin lacking the ability of Ca2+-binding. We then found that wildtype fortilin, but not fortilin(E58A/E60A), protected cells against thapsigargin-induced apoptosis, suggesting that the binding of fortilin to Ca2+ is required for fortilin to protect cells against Ca2+-dependent apoptosis. Together, these results suggest that fortilin is an intracellular Ca2+ scavenger, protecting cells against Ca2+-dependent apoptosis by binding and sequestering Ca2+ from the downstream Ca2+-dependent apoptotic pathways.",
keywords = "Apoptosis, Ca, Cell death, Fortilin, Thapsigargin",
author = "Potchanapond Graidist and Michio Yazawa and Moltira Tonganunt and Akiko Nakatomi and Lin, {Curtis Chun Jen} and Chang, {Jui Yoa} and Amornrat Phongdara and Kenichi Fujise",
year = "2007",
month = "12",
day = "1",
doi = "10.1042/BJ20070679",
language = "English (US)",
volume = "408",
pages = "181--191",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo

AU - Graidist, Potchanapond

AU - Yazawa, Michio

AU - Tonganunt, Moltira

AU - Nakatomi, Akiko

AU - Lin, Curtis Chun Jen

AU - Chang, Jui Yoa

AU - Phongdara, Amornrat

AU - Fujise, Kenichi

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Fortilin, a 172-amino-acid polypeptide present both in the cytosol and nucleus, possesses potent anti-apoptotic activity. Although fortilin is known to bind Ca2+, the biochemistry and biological significance of such an interaction remains unknown. In the present study we report that fortilin must bind Ca2+ in order to protect cells against Ca2+-dependent apoptosis. Using a standard Ca2+-overlay assay, we first validated that full-length fortilin binds Ca2+ and showed that the N-terminus (amino acids 1-72) is required for its Ca2+-binding. We then used flow dialysis and CD spectropolarimetry assays to demonstrate that fortilin binds Ca2+ with a dissociation constant (Kd) of approx. 10 μM and that the binding of fortilin to Ca2+ induces a significant change in the secondary structure of fortilin. In order to evaluate the impact of the binding of fortilin to Ca2+ in vivo, we measured intracellular Ca2+ levels upon thapsigargin challenge and found that the lack of fortilin in the cell results in the exaggerated elevation of intracellular Ca2+ in the cell. We then tested various point mutants of fortilin for their Ca2+ binding and identified fortilin(E58A/E60A) to be a double-point mutant of fortilin lacking the ability of Ca2+-binding. We then found that wildtype fortilin, but not fortilin(E58A/E60A), protected cells against thapsigargin-induced apoptosis, suggesting that the binding of fortilin to Ca2+ is required for fortilin to protect cells against Ca2+-dependent apoptosis. Together, these results suggest that fortilin is an intracellular Ca2+ scavenger, protecting cells against Ca2+-dependent apoptosis by binding and sequestering Ca2+ from the downstream Ca2+-dependent apoptotic pathways.

AB - Fortilin, a 172-amino-acid polypeptide present both in the cytosol and nucleus, possesses potent anti-apoptotic activity. Although fortilin is known to bind Ca2+, the biochemistry and biological significance of such an interaction remains unknown. In the present study we report that fortilin must bind Ca2+ in order to protect cells against Ca2+-dependent apoptosis. Using a standard Ca2+-overlay assay, we first validated that full-length fortilin binds Ca2+ and showed that the N-terminus (amino acids 1-72) is required for its Ca2+-binding. We then used flow dialysis and CD spectropolarimetry assays to demonstrate that fortilin binds Ca2+ with a dissociation constant (Kd) of approx. 10 μM and that the binding of fortilin to Ca2+ induces a significant change in the secondary structure of fortilin. In order to evaluate the impact of the binding of fortilin to Ca2+ in vivo, we measured intracellular Ca2+ levels upon thapsigargin challenge and found that the lack of fortilin in the cell results in the exaggerated elevation of intracellular Ca2+ in the cell. We then tested various point mutants of fortilin for their Ca2+ binding and identified fortilin(E58A/E60A) to be a double-point mutant of fortilin lacking the ability of Ca2+-binding. We then found that wildtype fortilin, but not fortilin(E58A/E60A), protected cells against thapsigargin-induced apoptosis, suggesting that the binding of fortilin to Ca2+ is required for fortilin to protect cells against Ca2+-dependent apoptosis. Together, these results suggest that fortilin is an intracellular Ca2+ scavenger, protecting cells against Ca2+-dependent apoptosis by binding and sequestering Ca2+ from the downstream Ca2+-dependent apoptotic pathways.

KW - Apoptosis

KW - Ca

KW - Cell death

KW - Fortilin

KW - Thapsigargin

UR - http://www.scopus.com/inward/record.url?scp=36749077202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36749077202&partnerID=8YFLogxK

U2 - 10.1042/BJ20070679

DO - 10.1042/BJ20070679

M3 - Article

C2 - 17705784

AN - SCOPUS:36749077202

VL - 408

SP - 181

EP - 191

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -